Reata Pharmaceuticals Statistics Share Statistics Reata Pharmaceuticals has 38.1M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 38.1M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 29.79M Failed to Deliver (FTD) Shares 680 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 2.39M, so 6.28% of the outstanding
shares have been sold short.
Short Interest 2.39M Short % of Shares Out 6.28% Short % of Float 8.14% Short Ratio (days to cover) 3.09
Valuation Ratios The PE ratio is -4.42 and the forward
PE ratio is null.
Reata Pharmaceuticals's PEG ratio is
-0.91.
PE Ratio -4.42 Forward PE n/a PS Ratio 622.68 Forward PS n/a PB Ratio -21 P/FCF Ratio -6.65 PEG Ratio -0.91
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Reata Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.75,
with a Debt / Equity ratio of -1.82.
Current Ratio 6.75 Quick Ratio 6.75 Debt / Equity -1.82 Debt / EBITDA -0.44 Debt / FCF -0.58 Interest Coverage -6.47
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $6.9K Profits Per Employee $-971.65K Employee Count 321 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -25K Effective Tax Rate 0.01%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.42, so Reata Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.42 52-Week Price Change n/a 50-Day Moving Average 159.77 200-Day Moving Average 95.71 Relative Strength Index (RSI) 84.69 Average Volume (20 Days) 954,093
Income Statement In the last 12 months, Reata Pharmaceuticals had revenue of 2.22M
and earned -311.9M
in profits. Earnings per share was -8.59.
Revenue 2.22M Gross Profit 2.22M Operating Income -270.15M Net Income -311.9M EBITDA -269.02M EBIT -270.15M Earnings Per Share (EPS) -8.59
Full Income Statement Balance Sheet The company has 42.31M in cash and 119.46M in
debt, giving a net cash position of -77.15M.
Cash & Cash Equivalents 42.31M Total Debt 119.46M Net Cash -77.15M Retained Earnings -1.57B Total Assets 502.59M Working Capital 276.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -204.27M
and capital expenditures -3.27M, giving a free cash flow of -207.54M.
Operating Cash Flow -204.27M Capital Expenditures -3.27M Free Cash Flow -207.54M FCF Per Share -5.71
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -12191.11% and -14074.95%.
Gross Margin 100% Operating Margin -12191.11% Pretax Margin -14076.08% Profit Margin -14074.95% EBITDA Margin -12140.12% EBIT Margin -12191.11% FCF Margin -9365.39%
